We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




X-Ray Crystallography Reveals Structure of the Arenavirus Binding Complex

By LabMedica International staff writers
Posted on 11 May 2016
Print article
Image: The structure gives scientists a new view of Lymphocytic choriomeningitis mammarenavirus (LCMV), a close relative of the Lassa fever virus (Photo courtesy of the Ollmann Saphire Laboratory, The Scripps Research Institute).
Image: The structure gives scientists a new view of Lymphocytic choriomeningitis mammarenavirus (LCMV), a close relative of the Lassa fever virus (Photo courtesy of the Ollmann Saphire Laboratory, The Scripps Research Institute).
A team of molecular virologists has established the three-dimensional structure of the intensely studied research tool, Lymphocytic choriomeningitis mammarenavirus (LCMV).

LCMV and the closely related, but much deadlier Lassa fever virus are arenaviruses, which exist worldwide and cause hemorrhagic fevers and neurological disease. These viruses are characterized by a single glycoprotein expressed on the viral surface that mediates entry into target cells. This glycoprotein, termed GPC, contains a membrane-associated signal peptide, a receptor-binding subunit termed GP1, and a fusion-mediating subunit termed GP2. Although GPC is a critical target of antibodies and vaccines, the structure of the metastable GP1-GP2 prefusion complex has remained undetermined for all arenaviruses.

When LCMV attacks a cell, attachment of the virus to host receptors through its surface glycoproteins initiates the process of replication. The virus is encapsulated into a vesicle inside the host cell, which creates a fusion of the virus and vesicle membranes. The viral ribonucleocapsid is then released into the cytoplasm of the host cell. The RNA-dependent, RNA-polymerase brought along with the virus initially binds to a promoter and begins transcription from negative-stranded to a positive-stranded mRNA. The formation of a strong hairpin sequence at the end of each gene terminates transcription. The mRNA strands are capped by the RNA-dependent, RNA-polymerase in the cytoplasm and are then subsequently translated into the four proteins essential for LCMV assembly. The ribonucleocapsid interacts with the Z matrix protein and buds on the cell membrane, releasing the virion to exit the infected cell.

In a paper published in the April 25, 2016, online edition of the journal Nature Structural & Molecular Biology, investigators at The Scripps Research Institute (La Jolla, CA, USA) described results of a long-term X-ray crystallography study that elucidated the crystal structure of the fully glycosylated prefusion GP1-GP2 complex of LCMV at a resolution of .35 nm.

The "double dimer" structure that was obtained revealed the conformational changes that the arenavirus glycoprotein must undergo to cause fusion and illustrated the fusion regions and potential oligomeric states.

"LCMV has been a beacon that has illuminated immunology and virology for decades," said senior author Dr. Erica Ollmann Saphire, professor of immunology and microbial science at The Scripps Research Institute. "This structure provides the missing roadmap to understand how to defend against its extremely lethal cousin, Lassa virus. It has moving parts. LCMV now looks like it sits between class I and class II viruses, making this structure a possible "fossil" of an intermediate evolutionary process."

Related Links:
The Scripps Research Institute

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Troponin I Test
Quidel Triage Troponin I Test
New
Silver Member
HPV Molecular Controls
ZeptoMetrix® HPV Type 16, 18, 45 & 68 Molecular Controls

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.